Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by GrahamBon Aug 22, 2023 4:04pm
64 Views
Post# 35600548

RE:RE:RE:RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$

RE:RE:RE:RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$The answer to you question should be self evident from a person that says "science first" 
Voice dictation 

Ok to move from the cherry picking of selective ceo posts-here are some more from a number of posters
We will have to wait for the final impact, but my deduction is minimal to no money from the upgrade.

Like I said-following the story with every meaningful PR or finacial data-will be here.
In this case I rate the PR as pure fluff...

SOURCE ceo.ca
@AGS The word "upgrade" was used in the first sentence so that should clear up all confusion lol. This was NOT A SALE. Period. I will use public NR from the company unless they amend it. Not. A. Sale. However this is a very good update and let me just get to huge opportunity staring us in the face - That Hospital is the2nd biggest children's hospital in London and are successfully using VMS and 2. Evelina London children’s heart services (cardiology) cares for around 6,000 patients each year. A very important piece for VPT to have established. Why? Keep reading...14 minutes ago
 
 
@Investor765 Careful for some missleading information posted here. Today's NR is NOT A SALE, hence not "fully paid for".
 
@Walkoverthestreet  I emailed Jonathan on today's PR and whether this was a sale or a free upgrade.  "This is a free upgrade offer to an important customer. The hospital is an important reference site for other potential buyers." Feel free to email him (address listed on PR).
So either GA is wrong or Jonathan is.and let IR do it as he’s not in the loop or has incorrect info. 2 about 2 hours ago

 
@Rocket67  @Walkoverthestreet I agree, I can't believe this hospital didn't ask for a 3.0 a while back.  I wonder if that initial NICE report was based on the 1.0 at this hospital.  Also, makes me wonder if they are going to re-apply to NHS/NICE.  And yes, GA has shown his propensity to overstate and fudge data.  He should get out of the NR loop altogether and VPT should stop playing investors for fools.  Give it to us straight so we can process the data instead of having to figure out what the hell they are saying.  I would have rather this NR stated that they upgraded for free because of the importance of it's use at that hospital.  2 about 2 hours ago
 
@AGS  Folks need to stop reading GA releases. They create more questions and are not always aligning with the NR. I do not believe we need him to "interpret" or explain the NR to us. We are smart enough. We can read. If people have questions they can go direct. 1 about 2 hours ago
@Samburns  @Rocket67 @Walkoverthestreet i agree about GA  2 about 2 hours ago

 
@Keys  This news or update or fluff…. It really doesn’t matter . It’s a prelude to the Upcoming conference. As @AGS stated Evelina London is part of Guy's and St Thomas NHS Trust. One of 5 main hospitals and I think that they will be presenting VMS+ at this scheduled symposium from what I can gather from this
 
<< Previous
Bullboard Posts
Next >>